cyclosporine has been researched along with Glaucoma in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 5 (26.32) | 29.6817 |
| 2010's | 8 (42.11) | 24.3611 |
| 2020's | 1 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Bartz-Schmidt, KU; Blak, M; Herrmann, T; Hurst, J; Klemm, P; Löscher, M; Melchinger, M; Schnichels, S; Schultheiss, M; Spitzer, MS; Zeck, G | 1 |
| Dai, Z; Sun, J; Sun, X; Yu, X | 1 |
| Brennan, D; Clark, A; Crotty, T; Irnaten, M; O'Brien, C; Papkovsky, D; Zhdanov, A | 1 |
| Bradley, JL; Dana, R; Evans, AM; Guerin, A; Pivneva, I; Stillman, IÖ | 1 |
| Dai, ZX; Song, XL; Sun, JG; Sun, XH; Yu, XB | 1 |
| Akpek, EK; Smith, RA | 1 |
| Zarbin, MA | 1 |
| Dada, T; Dhiman, R; Saini, M; Tandon, R; Vanathi, M | 1 |
| Dai, Z; Hong, J; Liu, X; Sun, J; Sun, X; Yu, X | 1 |
| Almodin, J; Fakhraie, G; Ichhpujani, P; Lopes, JF; Moster, MR; Spaeth, GL | 1 |
| Holland, EJ; Shimazaki, J; Shimmura, S; Shinozaki, N; Tsubota, K | 1 |
| Szaflik, J; Zaleska-Zmijewska, A | 1 |
| Allen, RC; Crouch, ER; Lattanzio, FA; Mitrev, PV; Williams, PB | 1 |
| Ashton, P; Blandford, DL; Jaffe, GJ; Martin, DF; Nussenblatt, RB; Pearson, PA | 1 |
| Champagne, ES; Gratzek, AT; Kaswan, RL; Martin, CL; White, SL | 1 |
| Kim, DM; Park, KH; Youn, DH | 1 |
| Donnenfeld, ED; Grossman, GA; Kanellopoulos, AJ; Perry, HD | 1 |
| Acheampong, A; D'Aversa, G; Donnenfeld, ED; Kanellopoulos, AJ; Perry, HD; Sforza, PD; Stern, M; Wallerstein, A | 1 |
4 review(s) available for cyclosporine and Glaucoma
| Article | Year |
|---|---|
Current treatment strategies for age-related ocular conditions.
Topics: Aged; Antibodies, Monoclonal, Humanized; Bevacizumab; Clinical Trials as Topic; Cyclosporine; Diabetes Mellitus; Diabetic Retinopathy; Disease Progression; Dry Eye Syndromes; Glaucoma; Glycated Hemoglobin; Humans; Macular Degeneration; Medication Adherence; Ophthalmic Solutions; Ophthalmologic Surgical Procedures; Ranibizumab; Receptors, Vascular Endothelial Growth Factor; Recombinant Fusion Proteins; Vascular Endothelial Growth Factor A | 2013 |
[Pharmacological methods improving the effectiveness of filtering procedures].
Topics: Antibiotics, Antineoplastic; Antibodies; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Cyclosporine; Filtering Surgery; Fluorouracil; Glaucoma; Growth Substances; Humans; Mitomycin; Treatment Outcome | 2004 |
Drugs for some common eye disorders.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiogenesis Inhibitors; Anti-Bacterial Agents; Antioxidants; Carbonic Anhydrase Inhibitors; Cholinergic Agonists; Conjunctivitis, Allergic; Conjunctivitis, Bacterial; Cyclosporine; Diuretics, Osmotic; Dry Eye Syndromes; Eye Diseases; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Macular Degeneration; Ophthalmic Solutions; Patient Compliance; Patient Selection; Photochemotherapy; Prostaglandins; Treatment Outcome; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A; Zinc | 2007 |
Review: implants.
Topics: Animals; Cyclosporine; Cytomegalovirus Retinitis; Delayed-Action Preparations; Drug Implants; Filtering Surgery; Fluorouracil; Ganciclovir; Glaucoma; Humans; Uveitis | 1994 |
1 trial(s) available for cyclosporine and Glaucoma
| Article | Year |
|---|---|
Effects of postoperative cyclosporine ophthalmic emulsion 0.05% (Restasis) following glaucoma surgery.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Blister; Conjunctiva; Cyclosporine; Double-Blind Method; Female; Glaucoma; Humans; Immunosuppressive Agents; Inflammation; Intraocular Pressure; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Prospective Studies; Time Factors; Trabeculectomy | 2009 |
14 other study(ies) available for cyclosporine and Glaucoma
| Article | Year |
|---|---|
Cyclosporine A Protects Retinal Explants against Hypoxia.
Topics: Animals; Apoptosis; Cell Hypoxia; Cell Line; Cell Survival; Cyclosporine; Glaucoma; Neuroprotective Agents; Organ Culture Techniques; Rats; Retina; Retinal Diseases; Retinal Ganglion Cells; Retinal Vein Occlusion; Tomography, Optical Coherence | 2021 |
Grooved Glaucoma Drainage Devices That Continuously Deliver Cyclosporine A Decrease Postsurgical Scar Formation in Rabbit Eyes.
Topics: Animals; Corneal Injuries; Cyclosporine; Disease Models, Animal; Follow-Up Studies; Glaucoma; Glaucoma Drainage Implants; Immunosuppressive Agents; Intraocular Pressure; Male; Postoperative Complications; Prosthesis Design; Rabbits; Retrospective Studies; Treatment Outcome; Visual Acuity | 2017 |
Activation of the NFAT-Calcium Signaling Pathway in Human Lamina Cribrosa Cells in Glaucoma.
Topics: Aniline Compounds; Blotting, Western; Calcineurin Inhibitors; Calcium; Calcium Signaling; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Cyclosporine; Extracellular Matrix; Fura-2; Gene Expression Profiling; Glaucoma; Humans; Hydrogen Peroxide; Microscopy, Confocal; NFATC Transcription Factors; Optic Disk; Oxidants; Real-Time Polymerase Chain Reaction; Transforming Growth Factor beta1; Xanthenes | 2018 |
Comorbidities and Prescribed Medications in Patients With or Without Dry Eye Disease: A Population-Based Study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Cataract; Comorbidity; Cyclosporine; Databases, Factual; Diabetes Mellitus, Type 2; Drug Prescriptions; Dry Eye Syndromes; Emulsions; Female; Glaucoma; Humans; Hypertension; Immunosuppressive Agents; International Classification of Diseases; Male; Middle Aged; Military Personnel; Ophthalmic Solutions; Retrospective Studies; Thyroid Diseases; United States | 2019 |
Cyclosporine A-loaded drug delivery systems inhibit scar formation after glaucoma surgery in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Cicatrix; Cyclosporine; Drug Delivery Systems; Glaucoma; Rabbits | 2019 |
Combination therapy to reduce conjunctival scarring after glaucoma surgery.
Topics: Alkylating Agents; Apoptosis; Calcium Channel Blockers; Cicatrix; Conjunctival Diseases; Cyclosporine; Drug Therapy, Combination; Enzyme Inhibitors; Fibroblasts; Filtering Surgery; Glaucoma; Humans; Mitomycin; Postoperative Complications; Staurosporine; Tenon Capsule; Verapamil | 2013 |
Topical cyclosporine to control ocular surface disease in patients with chronic glaucoma after long-term usage of topical ocular hypotensive medications.
Topics: Administration, Topical; Adult; Aged; Antihypertensive Agents; Chronic Disease; Cornea; Cyclosporine; Drug Combinations; Female; Glaucoma; Humans; Immunosuppressive Agents; Intraocular Pressure; Male; Microscopy, Confocal; Middle Aged; Nerve Fibers; Ophthalmic Solutions; Prospective Studies; Trigeminal Nerve; Trigeminal Nerve Diseases; Visual Acuity; Young Adult | 2015 |
Development of a novel CsA-PLGA drug delivery system based on a glaucoma drainage device for the prevention of postoperative fibrosis.
Topics: Animals; Cell Survival; Cells, Cultured; Chromatography, High Pressure Liquid; Cyclosporine; Drainage; Drug Carriers; Drug Liberation; Eye; Fibroblasts; Fibrosis; Fluorescein Angiography; Glaucoma; Immunohistochemistry; Intraocular Pressure; Lactic Acid; Microscopy, Electron, Scanning; Neovascularization, Physiologic; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Rabbits; Thermogravimetry | 2016 |
Efficacy and safety of international donor sharing: a single-center, case-controlled study on corneal transplantation.
Topics: Case-Control Studies; Cornea; Corneal Transplantation; Cyclosporine; Female; Follow-Up Studies; Glaucoma; Graft Rejection; Humans; Immunosuppressive Agents; Japan; Male; Middle Aged; Organ Preservation; Patient Selection; Racial Groups; Time Factors; Tissue and Organ Procurement; Treatment Outcome; United States | 2004 |
Cyclosporin as an adjunct to glaucoma filtration surgery.
Topics: Administration, Topical; Animals; Antibiotics, Antineoplastic; Combined Modality Therapy; Conjunctiva; Cyclosporine; Female; Filtering Surgery; Fistula; Glaucoma; Immunosuppressive Agents; Intraocular Pressure; Intraoperative Care; Mitomycin; Ophthalmic Solutions; Rabbits | 2005 |
Ophthalmic cyclosporine in equine keratitis and keratouveitis: 11 cases.
Topics: Administration, Topical; Adrenal Cortex Hormones; Animals; Cornea; Corneal Ulcer; Cyclosporine; Female; Glaucoma; Horse Diseases; Horses; Immunosuppressive Agents; Keratitis; Male; Retrospective Studies; Uveitis | 1995 |
Topical cyclosporine and glaucoma drainage implant surgery in rabbits.
Topics: Administration, Topical; Animals; Cell Division; Conjunctiva; Cyclosporine; Fibroblasts; Fibrosis; Filtering Surgery; Follow-Up Studies; Glaucoma; Immunosuppressive Agents; Intraocular Pressure; Ophthalmic Solutions; Postoperative Complications; Prostheses and Implants; Rabbits | 1996 |
Topical cyclosporin A in the management of postkeratoplasty glaucoma.
Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Cyclosporine; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratoplasty, Penetrating; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications; Risk Factors; Treatment Outcome | 1997 |
Topical Cyclosporine A in the management of postkeratoplasty glaucoma and corticosteroid-induced ocular hypertension (CIOH) and the penetration of topical 0.5% cyclosporine A into the cornea and anterior chamber.
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Anterior Chamber; Chromatography, High Pressure Liquid; Cornea; Cyclosporine; Female; Follow-Up Studies; Glaucoma; Glucocorticoids; Humans; Immunosuppressive Agents; Intraocular Pressure; Keratoplasty, Penetrating; Male; Middle Aged; Ocular Hypertension; Ophthalmic Solutions; Prospective Studies | 1998 |